Radiographic PFS in Metastatic CRPC More Than Doubles With Novel Combination

(MedPage Today)-San Francisco-Survival survival free of radial progress in prostate cancer resistant to the metasta (MCRPC) is more than twice with the addition of a targeted surveys treatment for standard therapy, which is a lover …